HPGD and colorectal carcinoma: HPGD has a significantly lower expression in in-house CRC tumor samples (p-value=4.63e-07, log2Fold-Change=-2.70) and pre-surgical cfRNA (p-value=1.67e-02, log2Fold-Change=-0.74).